Advertisement

ASO Author Reflections: Liver Transplantation for Hepatocellular Carcinoma

  • Tiffany C. L. Wong
  • Kelvin K. C. NgEmail author
ASO Author Reflections
  • 21 Downloads

Notes

Disclosure

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Lo C, Fan S, Liu C, Chan S, Ng I, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg. 2007;94(1):78–86.CrossRefGoogle Scholar
  2. 2.
    Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology. 2011;53(5):1570–1579.CrossRefGoogle Scholar
  3. 3.
    Azoulay D, Audureau E, Bhangui P, Belghiti J, Boillot O, Andreani P, et al. Living or brain-dead donor liver transplantation for hepatocellular carcinoma: a multicenter, western, intent-to-treat cohort study. Ann Surg. 2017;266(6):1035–1044.CrossRefGoogle Scholar
  4. 4.
    Wong TCL, Ng KKC, Fung JYY, Chan ACY, Cheung TT, Chok KSH, et al. Long-term survival outcome between living donor and deceased donor liver transplant for hepatocellular carcinoma: intention-to-treat and propensity score matching analyses. Ann Surg Oncol. 2019.  https://doi.org/10.1245/s10434-019-07206-0.Google Scholar
  5. 5.
    Li CX, Ling CC, Shao Y, Xu A, Li XC, Ng KT, et al. CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation. J Hepatol. 2016;65(5):944–952.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of SurgeryThe University of Hong KongPok Fu LamHong Kong
  2. 2.Department of SurgeryThe University of Hong Kong-Shenzhen HospitalShenzhenChina

Personalised recommendations